Andrea Anderson

Contributor

Phone Number

+1-780-990-0086

Email

Andrea Anderson covers genomics research studies and translational research for GenomeWeb. Find her on Twitter at @andyandy_tk.

Articles Authored by Andrea Anderson

Jan 14, 2020

Immunotherapy Response Prediction Improves With TMB Correction, Other Markers

Premium

Using corrected TMB and other variables allowed Johns Hopkins researchers to more accurately predict response to immune checkpoint blockade in lung cancer.

Jan 03, 2020

Stanford Team Proposes Automated Clinical Trial Accrual Strategy, Increased Trial Annotation

Premium

Researchers developed a feature mapping algorithm to pair cancer patients with precision oncology trials at Stanford but say increased clinical trial standardization is needed.

Dec 03, 2019

Oncologists, Patient Groups Eagerly Await Access to KRAS Inhibitors Based on Promising Early Data

Premium

At least one drugmaker is planning to submit for FDA approval of its KRAS inhibitor based on data from Phase I/II, single-arm trial in heavily pretreated lung cancer patients.

Oct 22, 2019

ROS1 Cancer Model Project Demonstrates Power of Patient Advocacy

The ROS1ders advocacy group is 500 patients strong and they are helping researchers establish cell lines to improve understanding of rare ROS1-positve cancers.

Oct 08, 2019

ESMO Trial Results Raise Possibility of Neoadjuvant Keytruda Use in Triple-Negative Breast Cancer

Premium

In KEYNOTE-522, early-stage TNBC patients on the immunotherapy and chemotherapy combination benefitted regardless of their PD-L1 expression status.

Oct 01, 2019

Sep 16, 2019

UK-Led Team Pushes for Broader BRCA Screening Policies With Data on Ashkenazi Population

Premium

The data showed that population screening for BRCA mutations in Ashkenazi Jewish population doesn't diminish quality of life or cause psychological distress.

Menu

Andrea Anderson

Immunotherapy Response Prediction Improves With TMB Correction, Other Markers

Stanford Team Proposes Automated Clinical Trial Accrual Strategy, Increased Trial Annotation

Oncologists, Patient Groups Eagerly Await Access to KRAS Inhibitors Based on Promising Early Data

ROS1 Cancer Model Project Demonstrates Power of Patient Advocacy

ESMO Trial Results Raise Possibility of Neoadjuvant Keytruda Use in Triple-Negative Breast Cancer

Phase III Trial Suggests Tecentriq Survival Benefit in Bladder Cancer Subgroup

Trial Data Reveals Progression Delay in Cholangiocarcinoma with Targeted IDH1 Drug

Clinical Trials Point to Broader Role for PARP Inhibitors in Advanced Ovarian Cancer

Carcinoma of Unknown Primary Investigators Pursue Molecular Targets to Tailor Treatments

UK-Led Team Pushes for Broader BRCA Screening Policies With Data on Ashkenazi Population

Breaking News

UK's NICE Will Not Recommend Osimertinib for Untreated Non-Small Cell Lung Cancer

Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement

T Cell Assessment in Primary Melanomas Can Help Predict Metastatic Recurrence

Genetic Testing Challenges in Oncology: Patient Told Genetic Test was Negative Turns out to be MAP Carrier

FDA Accepts Bridge Biotherapeutics' Investigational New Drug Application for Lung Cancer Drug

JP Morgan Healthcare, Day 4: Five Prime Therapeutics and Gritstone Oncology

Sponsorships